{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:08:01Z","timestamp":1778926081249,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tranon.2026.102783","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:07:26Z","timestamp":1777334846000},"page":"102783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anoctamin 5 as a protective factor in prostate cancer: Insights from WGCNA, machine learning, and experimental analysis, with a focus on the anoctamin family"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3032-9379","authenticated-orcid":false,"given":"Jian-she","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-mei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-jun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-rong","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102783_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102783_bib0002","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tranon.2026.102783_bib0003","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors-A systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tranon.2026.102783_bib0004","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3390\/biomedicines13051182","article-title":"Normal weight, overweight and obesity conditions associated to prostate neoplasm stages-A systematic review and meta-analysis","volume":"13","author":"Vitale","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.tranon.2026.102783_bib0005","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.mcna.2020.08.007","article-title":"Screening for prostate cancer","volume":"104","author":"Carlsson","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.tranon.2026.102783_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-025-01067-3","article-title":"Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study","author":"B\u00fcttner","year":"2026","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"10.1016\/j.tranon.2026.102783_bib0007","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.euo.2024.11.005","article-title":"Apalutamide in metastatic castration-sensitive prostate cancer: results from the Multicenter real-world ARON-3 study","volume":"8","author":"Santoni","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.tranon.2026.102783_bib0008","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMa"},{"key":"10.1016\/j.tranon.2026.102783_bib0009","article-title":"ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102783_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1200\/JCO.19.01638","article-title":"Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study","volume":"38","author":"Antonarakis","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102783_bib0011","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1911440","article-title":"Olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0012","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3390\/cancers14040907","article-title":"PARP inhibitors and radiometabolic approaches in metastatic castration-resistant prostate cancer: what\u2019s now, what\u2019s new, and what\u2019s coming?","volume":"14","author":"Marchetti","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102783_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413519","article-title":"An insight on novel molecular pathways in metastatic prostate cancer: a focus on DDR, MSI and AKT","volume":"22","author":"Mollica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102783_bib0014","doi-asserted-by":"crossref","unstructured":"Shen J., Pachynski R., Nordquist L., Adra N., Bilen M., Aggarwal R., Reichert Z., Schweizer M., Xu D., Patel M., Zhang J., Shi W., L\u2019Heureux D.Z., Tagawa S. Abstract CT121: ARX517, an anti-PSMA ADC targeting mCRPC resistant or refractory to standard therapies: a phase 1 dose escalation and dose expansion study (ARX517-2011, NCT04662580). Cancer Res. 2023; 83:CT121.","DOI":"10.1158\/1538-7445.AM2023-CT121"},{"key":"10.1016\/j.tranon.2026.102783_bib0015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12916-025-04348-9","article-title":"Large language models in clinical trials: applications, technical advances, and future directions","volume":"23","author":"Lin","year":"2025","journal-title":"BMC. Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0016","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1016\/S1470-2045(19)30149-4","article-title":"Big data and machine learning algorithms for health-care delivery","volume":"20","author":"Ngiam","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2026.102783_bib0017","doi-asserted-by":"crossref","first-page":"Article17","DOI":"10.2202\/1544-6115.1128","article-title":"A general framework for weighted gene co-expression network analysis","volume":"4","author":"Zhang","year":"2005","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.tranon.2026.102783_bib0018","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41746-025-01930-6","article-title":"Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: advancing precision oncology","volume":"8","author":"Wang","year":"2025","journal-title":"NPJ. Digit. Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0019","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","article-title":"A guide to machine learning for biologists","volume":"23","author":"Greener","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2026.102783_bib0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2012.05.020","article-title":"A support vector machine-recursive feature elimination feature selection method based on artificial contrast variables and mutual information","volume":"910","author":"Lin","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.tranon.2026.102783_bib0021","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/widm.1072","article-title":"Overview of random forest methodology and practical guidance with emphasis on computational biology and bioinformatics","volume":"2","author":"Boulesteix","year":"2012","journal-title":"WIREs Data Min. Knowl."},{"key":"10.1016\/j.tranon.2026.102783_bib0022","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1093\/bioinformatics\/bti602","article-title":"an integrated analytical front-end application for bioinformatics","volume":"21","author":"Abyzov","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.102783_bib0023","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/physrev.00039.2011","article-title":"Structure and function of TMEM16 proteins (anoctamins)","volume":"94","author":"Pedemonte","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tranon.2026.102783_bib0024","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature09583","article-title":"Calcium-dependent phospholipid scrambling by TMEM16F","volume":"468","author":"Suzuki","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.102783_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jmb.2014.09.028","article-title":"TMEM16 proteins: unknown structure and confusing functions","volume":"427","author":"Picollo","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tranon.2026.102783_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300881","article-title":"ANO1-Mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts","volume":"10","author":"Jiang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tranon.2026.102783_bib0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/jpm13020295","article-title":"ANO4 Expression is a potential prognostic biomarker in non-metastasized clear cell renal cell carcinoma","volume":"13","author":"Al Sharie","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0028","article-title":"ANO6 is a reliable prognostic biomarker and correlates to macrophage polarization in breast cancer","volume":"102","author":"Tang","year":"2023","journal-title":"Med"},{"key":"10.1016\/j.tranon.2026.102783_bib0029","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/ijc.31746","article-title":"ANO7 is associated with aggressive prostate cancer","volume":"143","author":"Kaikkonen","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2026.102783_bib0030","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1002\/cam4.2909","article-title":"Genetic association analysis identifies a role for ANO5 in prostate cancer progression","volume":"9","author":"Yu","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0031","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","article-title":"Diagnostic and therapeutic strategies for prostate cancer","volume":"46","author":"Nguyen-Nielsen","year":"2016","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.tranon.2026.102783_bib0032","first-page":"265","article-title":"Expectant management for men with early stage prostate cancer","volume":"65","author":"Filson","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102783_bib0033","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers13030546","article-title":"Bone targeting agents in patients with metastatic prostate cancer: state of the art","volume":"13","author":"Mollica","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102783_bib0034","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2026.102783_bib0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/genes12010087","article-title":"K-module algorithm: an additional step to improve the clustering results of WGCNA Co-expression networks","volume":"12","author":"Hou","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.tranon.2026.102783_bib0036","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/molecules23010052","article-title":"Selecting feature subsets based on SVM-RFE and the overlapping ratio with applications in bioinformatics","volume":"23","author":"Lin","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.tranon.2026.102783_bib0037","first-page":"196","article-title":"A comparative study on decision tree and random forest using R tool","author":"T","year":"2015","journal-title":"IJARCCE"},{"key":"10.1016\/j.tranon.2026.102783_bib0038","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","article-title":"GOSemSim: an R package for measuring semantic similarity among GO terms and gene products","volume":"26","author":"Yu","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.102783_bib0039","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.2008.294","article-title":"The analysis of survival data in nephrology: basic concepts and methods of cox regression","volume":"74","author":"van Dijk","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.tranon.2026.102783_bib0040","article-title":"Comprehensive analysis of biomarkers for prostate cancer based on weighted gene co-expression network analysis","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.tranon.2026.102783_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113029","article-title":"The gene expression landscape of prostate cancer BM reveals close interaction with the bone microenvironment","volume":"23","author":"Saraji","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102783_bib0042","article-title":"Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102783_bib0043","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41419-018-0735-2","article-title":"Inhibition of ANO1\/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-\u03b1 signaling","volume":"9","author":"Song","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.tranon.2026.102783_bib0044","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","article-title":"Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity","volume":"56","author":"Park","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.tranon.2026.102783_bib0045","article-title":"Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.102783_bib0046","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.102783_bib0047","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.102783_bib0048","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur. J. Immunol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:20:23Z","timestamp":1778923223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":48,"alternative-id":["S1936523326001208"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102783","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anoctamin 5 as a protective factor in prostate cancer: Insights from WGCNA, machine learning, and experimental analysis, with a focus on the anoctamin family","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102783"}}